Tipo de artículo
Condición
Encuadernación
Más atributos
Ubicación del vendedor
Valoración de los vendedores
Publicado por LAP LAMBERT Academic Publishing Mai 2017, 2017
ISBN 10: 3659829013ISBN 13: 9783659829017
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
Libro Impresión bajo demanda
Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Acute lymphoblastic leukemia (ALL) is the most common tumor in children, and although of high cured, relapsed ALL remains a leading cause of ALL prevalence in children. With increasing age, the frequency of genetic alterations associated with poor outcome such as BCR-ABL1 are more common. With the exception of tyrosine kinase inhibitors (TKIs) current therapies do not target specific genetic alterations and are associated with short and long-term toxicity that limit the possibility of lifting escalating dose. So, it is important to determine the genetic alterations of leukemogenesis, to manage the therapeutic strategies of ALL patients. These studies also highlights. Approximately 70-75% of ALL patients have got a chromosomal alteration detectable by karyotyping , FISH, or molecular techniques. Although these rearrangements are important initiating events in leukemogenesis and are widely used in diagnosis and risk stratification algorithms, they are insufficient to fully explain leukemogenesis. It is now known that the majority of ALL cases are characterized by distinct sequence mutations. 180 pp. Englisch.
Publicado por LAP LAMBERT Academic Publishing, 2017
ISBN 10: 3659829013ISBN 13: 9783659829017
Librería: AHA-BUCH GmbH, Einbeck, Alemania
Libro Impresión bajo demanda
Taschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Acute lymphoblastic leukemia (ALL) is the most common tumor in children, and although of high cured, relapsed ALL remains a leading cause of ALL prevalence in children. With increasing age, the frequency of genetic alterations associated with poor outcome such as BCR-ABL1 are more common. With the exception of tyrosine kinase inhibitors (TKIs) current therapies do not target specific genetic alterations and are associated with short and long-term toxicity that limit the possibility of lifting escalating dose. So, it is important to determine the genetic alterations of leukemogenesis, to manage the therapeutic strategies of ALL patients. These studies also highlights. Approximately 70-75% of ALL patients have got a chromosomal alteration detectable by karyotyping , FISH, or molecular techniques. Although these rearrangements are important initiating events in leukemogenesis and are widely used in diagnosis and risk stratification algorithms, they are insufficient to fully explain leukemogenesis. It is now known that the majority of ALL cases are characterized by distinct sequence mutations.
Publicado por LAP LAMBERT Academic Publishing, 2017
ISBN 10: 3659829013ISBN 13: 9783659829017
Librería: moluna, Greven, Alemania
Libro Impresión bajo demanda
Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Al-Amili Wiaam AhmedDr. Wiaam Ahmed Al-Amili, ph.D Cytogenetic and Molecular Genetic, work at Institute of Genetic Engineering and Biotechnology for Higher Studies, University of Baghdad, has many published papers in the field of sp.
Publicado por LAP LAMBERT Academic Publishing, 2017
ISBN 10: 3659829013ISBN 13: 9783659829017
Librería: Revaluation Books, Exeter, Reino Unido
Libro
Paperback. Condición: Brand New. 180 pages. 8.66x5.91x0.41 inches. In Stock.